CeriBell (NASDAQ:CBLL) Shares Gap Down After Earnings Miss

CeriBell, Inc. (NASDAQ:CBLL) gapped down prior to trading on Tuesday following a dissappointing earnings announcement. The stock had previously closed at $20.06, but opened at $18.54. CeriBell shares last traded at $16.5950, with a volume of 88,801 shares traded.

The company reported ($0.52) EPS for the quarter, missing analysts’ consensus estimates of ($0.39) by ($0.13). CeriBell had a negative return on equity of 31.77% and a negative net margin of 59.97%.The company had revenue of $26.49 million for the quarter, compared to the consensus estimate of $26.09 million.

Analyst Upgrades and Downgrades

CBLL has been the topic of several recent analyst reports. Weiss Ratings reissued a “sell (d-)” rating on shares of CeriBell in a research report on Monday, April 6th. BTIG Research reiterated a “buy” rating and set a $30.00 price target on shares of CeriBell in a report on Wednesday, January 28th. Finally, Canaccord Genuity Group set a $25.00 price objective on CeriBell in a research note on Tuesday. One equities research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $22.20.

Insider Transactions at CeriBell

In other news, VP David Foehr sold 4,560 shares of the stock in a transaction on Tuesday, March 3rd. The stock was sold at an average price of $17.80, for a total transaction of $81,168.00. Following the completion of the transaction, the vice president owned 17,550 shares in the company, valued at approximately $312,390. This represents a 20.62% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CTO Raymond Woo sold 11,112 shares of the business’s stock in a transaction dated Wednesday, April 1st. The shares were sold at an average price of $18.56, for a total value of $206,238.72. Following the completion of the sale, the chief technology officer owned 166,912 shares in the company, valued at $3,097,886.72. This represents a 6.24% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 175,119 shares of company stock valued at $3,310,772 in the last three months. 20.10% of the stock is currently owned by company insiders.

Institutional Trading of CeriBell

Hedge funds and other institutional investors have recently modified their holdings of the business. Emerald Mutual Fund Advisers Trust boosted its holdings in CeriBell by 58.2% in the 3rd quarter. Emerald Mutual Fund Advisers Trust now owns 155,360 shares of the company’s stock worth $1,785,000 after buying an additional 57,175 shares during the period. CenterBook Partners LP boosted its holdings in shares of CeriBell by 448.0% in the third quarter. CenterBook Partners LP now owns 476,554 shares of the company’s stock worth $5,476,000 after acquiring an additional 389,584 shares during the period. JPMorgan Chase & Co. raised its stake in shares of CeriBell by 8.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 411,180 shares of the company’s stock valued at $4,724,000 after purchasing an additional 31,177 shares during the period. GSA Capital Partners LLP purchased a new stake in CeriBell during the 3rd quarter worth about $158,000. Finally, TimesSquare Capital Management LLC boosted its stake in CeriBell by 2.6% in the 3rd quarter. TimesSquare Capital Management LLC now owns 817,645 shares of the company’s stock worth $9,395,000 after purchasing an additional 20,700 shares during the period.

CeriBell Stock Down 16.9%

The firm has a market cap of $631.10 million, a PE ratio of -11.34 and a beta of 0.99. The company has a current ratio of 9.73, a quick ratio of 9.35 and a debt-to-equity ratio of 0.13. The stock has a fifty day simple moving average of $19.21 and a two-hundred day simple moving average of $18.81.

About CeriBell

CeriBell Corp (NASDAQ: CBLL) is a healthcare technology company specializing in the design, manufacture and sale of automated newborn hearing screening devices. The company offers a suite of medical diagnostic tools based on otoacoustic emissions (OAE) and auditory brainstem response (ABR) technologies, enabling early detection of auditory impairments in infants. CeriBell’s solutions are used in hospitals, birthing centers and audiology clinics to support universal newborn hearing screening programs aimed at improving language development outcomes through prompt intervention.

The company’s product portfolio includes handheld and desktop screening units, proprietary software for data management, and accessories designed to streamline testing workflows.